Connecticut Innovations
Venture Capital
Active
New Haven, United States
314
6M
229
10.83
64
0.27
31
- Stages of investment
- Areas of investment
Summary
Connecticut Innovations appeared to be the Corporate Investor, which was created in 1995. The main department of described Corporate Investor is located in the Rocky Hill. The fund was located in North America if to be more exact in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Primeter eSecurity, NeuVis, Budderfly. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Information Technology, Pharmaceutical.
This Connecticut Innovations works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2018. The high activity for fund was in 2013. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Connecticut Innovations is 5-10 millions dollars. Considering the real fund results, this Corporate Investor is 19 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 7-12 investment rounds annually. Deals in the range of 5 - 10 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Connecticut Innovations, startups are often financed by Ironwood Capital, MassChallenge, Advantage Capital. The meaningful sponsors for the fund in investment in the same round are Ironwood Capital, Elm Street Ventures, YEI Innovation Fund. In the next rounds fund is usually obtained by Ironwood Capital, Advantage Capital, The Vertical Group.
Besides them, we counted 8 critical employees of this fund in our database.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
- Check size
- 250K — 1M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 314
- Lead investments
- 64
- Exits
- 31
- Rounds per year
- 10.83
- Follow on index
- 0.27
- Investments by industry
- Health Care (111)
- Biotechnology (83)
- Software (61)
- Medical (43)
- Medical Device (34) Show 221 more
- Investments by region
-
- United States (290)
- Israel (8)
- Canada (6)
- Belgium (1)
- India (1) Show 4 more
- Peak activity year
- 2020
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 7M
- Group Appearance index
- 0.65
- Avg. company exit year
- 11
- Avg. multiplicator
- 0.52
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Modifi Bio | 16 Oct 2023 | Biotechnology, Medical, Therapeutics | Seed | 4M | United States, Connecticut, New Haven |
| RNAConnect | 01 May 2023 | Seed | United States, Connecticut, Branford |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.